Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Theacrine is a naturally occurring purine alkaloid structurally similar to caffeine and found in certain teas (notably Camellia assamica var. kucha) and plants such as Cupuaçu. It is marketed under the brand name TeaCrine. Theacrine acts primarily as a central nervous system stimulant at higher doses and may have sedative effects at lower doses. Its mechanism of action involves antagonism of adenosine receptors (A1 and A2A), which reduces fatigue and promotes alertness—similar to caffeine—but with less habituation or cardiovascular stimulation. Theacrine also appears to modulate dopaminergic pathways by activating dopamine receptors involved in motivation and mood enhancement[5][6][8]. Additional reported effects include anti-inflammatory activity via interference with histamine and serotonin signaling[3], antioxidant properties[4], potential improvements in cognitive function and energy levels[5][6], as well as possible benefits for lipid metabolism[7]. It is primarily used as an ingredient in dietary supplements aimed at enhancing mental performance or physical energy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on theacrine.